Combinatorial approaches to catalysis have made an impact in targeted transformation development, including silvermediated carbene insertion, [1] scandium/pybox-based (pybox = bis(oxazolinyl)pyridine) asymmetric cyclopropanation, [2] and rhodium/iridium-based asymmetric hydrogenation.[3] Useful design elements have emerged from these studies, for example, the value of ligand self-assembly, [4] or of the inclusion of peptide-like structural elements [5][6][7] in building ligand arrays. Efficient screening methods are of paramount importance for such efforts. Methods based on fluorescence, [8] REMPI, [9] MS, [10] NMR, [11] and IR thermography [12] have appeared. A chromophore may be installed into the substrate [13] or product [14] of the reaction under study. Alternatively, one can exploit chromophores inherent in proteins [15] or enzyme-associated reactions, [16] and use these sensors to report back on product formation and composition.Our group has developed an in situ enzymatic screening (ISES) approach whereby an organometallic reaction under study is coupled to an enzymatic reporting reaction in real time.[17] This screening method led to the discovery of the first asymmetric allylic amination with nickel(0) [18] and to the identification of novel salen [salen = N,N'-bis(salicylidene)-ethylenediamine)] ligands with promise for asymmetric synthesis.